Covid-19 and the ‘new normal’: are remote video consultations here to stay? by Bidmead, Elaine & Marshall, Alison
Bidmead, Elaine and Marshall, Alison (2020) Covid-19 and the ‘new normal’: are
remote video consultations here to stay? British Medical Bulletin . 
Downloaded from: http://insight.cumbria.ac.uk/id/eprint/5667/
Usage of  any items from the University  of  Cumbria’s institutional repository ‘Insight’ must  conform to the
following fair usage guidelines.
Any item and its associated metadata held in the University of Cumbria’s institutional repository Insight (unless
stated otherwise on the metadata record) may be copied, displayed or performed, and stored in line with the JISC
fair dealing guidelines (available here) for educational and not-for-profit activities
provided that
• the authors, title and full bibliographic details of the item are cited clearly when any part
of the work is referred to verbally or in the written form 
• a hyperlink/URL to the original Insight record of that item is included in any citations of the work
• the content is not changed in any way
• all files required for usage of the item are kept together with the main item file.
You may not
• sell any part of an item
• refer to any part of an item without citation
• amend any item or contextualise it in a way that will impugn the creator’s reputation
• remove or alter the copyright statement on an item.
The full policy can be found here. 
Alternatively contact the University of Cumbria Repository Editor by emailing insight@cumbria.ac.uk.




During the UK Covid-19 lockdown, video consultations (telemedicine) were encouraged. The extent 
of usage, and to which concerns to earlier implementation were set aside, is unknown; this is worthy 
of exploration as data becomes available. 
• Sources of data 
Published case studies, editorials, news articles and government guidance. 
• Areas of agreement 
Video can be clinically effective, especially where patients cannot attend due to illness or infection 
risk. Patients are positive; they can benefit from savings in time and money. Adoption of 
telemedicine is hindered by a range of known barriers including clinician resistance due to 
technological problems; disrupted routines; increased workload; decreased work satisfaction, and 
organizational readiness. 
• Areas of controversy 
Despite policy impetus and successful pilots, telemedicine has not been adopted at scale. 
• Growing points 
Increased use of telemedicine during the Covid-19 crisis presents opportunities to obtain robust 
evidence of issues and create service transformation effectively. 
• Areas timely for developing research. 
Examination of telemedicine use during the Covid-19 crisis to ensure that the benefits and usage 
continue into the post-lockdown, ‘new normal’ world.  
Introduction and background 
Over the previous decade, video conferencing has existed as a mature technology (e.g. FaceTime, 
Skype, Lync, Webex), used widely in both social and professional contexts. Responding to this 
opportunity, many innovative individuals within the health professions undertook painstaking 
practice and service development work to devise clinical protocols for a range of remote 
consultation interventions, referred to here as Telemedicine (see for example Fetal Telemedicine1; 
Telepsychiatry2; Teleswallowing3). These individuals acted as champions, often seeking external 
funding and promoting their own work to management, colleagues and professional institutions. 
Their work focused initially on designing and testing clinical validity and efficacy: could the patient 
receive (at least) the same standard of care over video as they would face to face? Some work was 
often necessary with technology providers and internal support services to adapt the products being 
used. These innovators often made the assumption that if they could demonstrate clinically efficacy, 
managers and colleagues would immediately choose to implement their innovation. It was expected 
that the decision would be largely driven by financial factors. Winning arguments would come from 
the ability to reduce hospital admissions through more timely intervention, the reduction of staff 
travel to service users, and efficiencies to be gained through ‘productionising’ interventions. Rarely 
was the argument for reducing infection risk used, although it could have been.  
Funding was duly made available to these clinical digital champions, often from external bodies such 
as National Institute for Health Research or an Academic Health Science Networks, for pilots, and 
academic partners engaged to undertake independent evaluation. However, despite a large body of 
work, progression from pilot to mainstream adoption proved surprisingly limited4,5,6,7,8.  The reasons 
can be found in some of the independent evaluation studies and are discussed below; no new data 
were generated or analysed in support of this review.  
In late March 2020, the UK Government imposed ‘lockdown’ throughout the UK, making it illegal for 
citizens to leave home unless they had specific, ‘essential’ reasons, in order to minimise the scale of 
Covid-19 across the country. During this period, working from home was encouraged ‘where 
possible’.   With regards to health care, whereas governments in Australia and the US had 
encouraged the use of technology for remote consultations, and backed this up with substantial 
funding, the UK government did not9 - although the Scottish government did accelerate funding for 
telemedicine9.  Fisk et al.9 attribute this lack of promotion to an apparent ‘general lack of developed 
services’ in the UK.  
On 17 March 2020, NHS England directed NHS trusts, GP practices and other providers of NHS 
services to ‘redirect staff and resources’ in preparation for the expected rise in Covid-19 cases10. This 
included the postponement of non-urgent elective surgeries and the urgent discharge of patients 
‘medically fit to leave’. Brief mention was made to video consultation in this document, but only in 
relation to older and vulnerable people who were shielding, and the redeployment of vulnerable 
staff.  A follow-up directive on 19 March laid bare the coming restrictions in access to health care, 
with face-to-face consultation being discouraged unless necessary, and remote consultation/virtual 
support being encouraged11. Further, information governance regulations, often hitherto regarded 
as regulatory barriers, were relaxed12.  Healthcare staff were given permission to use ‘mobile 
messaging’ and ‘video conferencing tools such as Skype, WhatsApp, Facetime’ as well as to use 
personal devices to support remote consultation ‘where there is no practical alternative’12.  Some 
professional bodies, the Chartered Society of Physiotherapists13 for example, developed rapid 
guidelines on video consultation. And a host of fast-tracked academic papers have advised on how 
to do video (including, amongst others, ‘quick tips’ for outpatient video consultations14; ‘virtual 
urology clinic’15; chronic pain management16; video consultations for Covid-1917; Telepalliative 
medicine18; Teleurology19; cardiac rehabilitation20; digital mental health21).   
Consequently, the use of telemedicine was perceived as an appropriate response to lockdown and 
resulted in increased use globally22. Although telemedicine use is reported to have increased in 
Scotland9, how far it impacted in the rest of UK is yet to be determined. 
Nevertheless, a number of questions arise, which are discussed in more detail below: 
- Are the reasons for reluctance to use video in the past no longer valid? 
- Are the reasons temporarily invalid, during the crisis period, but will become important 
again once this is past? 
- Can we learn from both the previous concerns and the current usage to implement video 
consultations effectively in the longer term? 
Discussion  
The impact of the current crisis on provision of non-Covid-19 healthcare has been highlighted with 
many concerns (for example, affecting usage of emergency care23; cancer survival rates24, and access 
to mental health support25). Telemedicine is perceived as a possible solution. Telemedicine has 
already been used to communicate directly with patients in their own homes26, as well as for 
consultations with patients and/or clinicians in other settings, for example, between district general 
hospitals and tertiary centres1; nursing home staff and allied health professionals3; care homes and 
Digital Care Hubs27. In these examples, telemedicine was seen as a way to increase access to 
healthcare for people living in remote/rural areas for whom limited access was the norm; this is now 
the new normal for most.  It is worth noting that patients’ views are largely positive, although there 
exists less systematic research into their experience. Notwithstanding, patients can be motivated by 
convenience and cost savings, as telemedicine means their personal travel can be avoided1,28. In the 
current context, patients will likely be motivated by the reduction of risk of infection and by some 
contact with the health service being better than no contact at all. 
The academic literature highlights known barriers and enablers to technological innovations in 
health settings5,6. Key among the barriers is resistance from clinical users. Recurring concerns by 
health professionals, who have piloted the use of video consultations, are useful to guide evaluation 
of current usage. The major concerns from our research are collated below29: 
i. Low confidence that the technology will work, or that support will be provided; 
ii. Dissonance with professional identity relating to issues of accountability and negative 
impacts on the staff-patient relationship - not comfortable with video-distancing, 
missing out on body language cues, feeling of being de-skilled. 
iii. Reduced job satisfaction (tiredness, eye strain, missing out on travel ‘downtime’ 
between consultations); 
iv. Fears of job losses; 
v. Concerns that patients are being offered ‘second best’ to reduce costs; 
vi. Concerns that some patients, particularly the elderly, will not be able to use the 
technology. 
Greenhalgh et al. identified four elements of clinician resistance to information and communication 
technology: resistance to ‘the nature and justification for the policy’ underpinning the innovation, 
resistance to the sociomaterial constraints of the technology, resistance to compromised 
professional practice, and resistance to compromised professional relationships30.   
Resistance to Policy relates to the underlying case for the implementation of technology. Clinical 
staff have often doubted the need for telemedicine and have struggled to comprehend its value to 
their service and/or practice4,8,9.  It is important that user stakeholders understand why innovation is 
happening and what will be the ‘relative advantages’31. The Technology Acceptance Model32,33 
identifies two main factors influencing the adoption of a technology or innovation: ‘perceived 
usefulness’ and ‘perceived ease of use’. Helping potential users to understand the usefulness of the 
innovation will help gain their acceptance.   
Given the current Covid-19 crisis, one would imagine clinical staff to be more inclined to see video as 
a solution and be more attuned to the ‘relative advantages’ and ‘perceived usefulness’ of remote 
consultation. Nevertheless, one should not underestimate the importance of providing opportunities 
for ‘sense making’ wherein staff can develop shared understandings of purpose, the potential 
benefits, and what is expected from them, which are necessarily absent in such a rapid rollout as we 
see in the current crisis. Many authors recommend the use of clinical digital champions as facilitators 
of telehealth implementation4,6.  Digital champions can legitimate an innovation by interpreting and 
disseminating evidence, and influencing stakeholders through enthusiastic promotion to colleagues, 
senior managers and service users.  
Moreover, staff engagement is beneficial for gaining ‘cognitive participation’ or ‘buy-in’34 and fosters 
‘a sense of ownership’6.  Zanaboni and Wootton argue that adoption is ‘significantly correlated with 
adopters’ perceptions of the advantages’; telemedicine is successful and adopted ‘when it is 
perceived as a benefit and as a solution to political and medical issues’8, which it surely must be at 
this time. During the pandemic, telemedicine is being used, but we do not know how it is perceived 
by staff users or whether they see it as a valuable tool for their clinical mission. Moreover, we 
cannot tell whether this is seen as a long-term service transformation or whether clinical staff will 
revert to routine practise at the first opportunity. 
The Sociomaterial Constraints of the technology refers to the ‘the material properties and limitations 
of the technology under conditions of expected use’30.  The Technology Acceptance Model refers 
instead to ‘perceived ease of use’32,33. Technological problems are a known barrier to 
acceptance3,4,6,29. The fact that rollout of new technology in the NHS has been plagued by technical 
problems is a major issue which cannot be underestimated and is still an issue now35. Already 
stressed staff are extremely wary of technical unreliability and its ability to compromise their 
overloaded workflows, which are organised so that any delay can be critical.  Complex systems that 
are difficult to use can be problematic and have led users to avoid or reject such new ways of 
working. In the current climate, where there is not time for trialability30, it may be that staff have no 
other option than to stick with it and to make it work. Nonetheless, many authors highlight the 
importance of having easy-to-use, reliable equipment4,6,8,36 that can be adapted to the local context6.  
The availability of technical support is also recommended4,6.  
Another issue, relating to ‘perceived ease of use’ is the compatibility, or alignment, of the new 
service to existing practices, pathways and workflows. Technological innovation can disrupt 
established routines, and a lack of fit between the innovation and normal practice can become a 
barrier to acceptance4,5,6. Vuononvirta et al. have highlighted the intransigent nature of routine 
practices due to habituation which ‘has made them easy and fluent for health professionals’36.  
Consequently, for clinicians, telemedicine is ‘almost always more time and trouble than practising in 
the ordinary way’ due to the ‘additional effort and technical expertise required’8. Compatibility also 
correlates with ‘perceived usefulness’, and, subsequently, attitudes towards technological 
innovations; good alignment facilitates use. Therefore, incorporating workflow analysis into system 
design is recommended6.  Where a lack of alignment is unavoidable then pathway redesign may be 
necessary. 
In normal times, rigorous planning for implementation would be recommended6.  In the current 
situation, systems will have had to be adapted, rolled out and staff trained in a very short time, 
within an already stressful situation. This can only have been achieved through significant diversion 
of resources and management priority.  Support from senior staff and strong leadership has been 
identified as a key enabler of innovation4,5. Greenhalgh et al. highlight the importance of an 
organization’s readiness for innovation, pointing to factors such as good leadership and managerial 
relations; slack resources and the encouragement of risk-taking, as opposed to organizations that 
are under pressure due to limited resources, ‘weak leadership and managerial relations’ and an 
aversion to risk-taking5. It may be that services that quickly transitioned to telemedicine resembled 
the former rather than the latter. However, the usefulness of the technology is at the forefront of 
the corporate mind, as video consultations may have proved to be critical to maintaining core 
services safely.  
Furthermore, several studies have highlighted the altered staff-patient relationship caused by 
telemedicine; this is often viewed negatively3,4,36. Many health professionals view face to face 
consultation as the exemplar of good care; any change to this is felt as threatening. Undoubtedly, 
consultations requiring physical examination are unsuitable for telemedicine, yet many consultations 
involve only talking. During lockdown, most face-to-face consultations were suspended meaning no 
consultations at all. Notwithstanding, staff have voiced concerns about the impact of telemedicine 
on the staff–patient relationship, communications can be interrupted by problems with equipment 
which then inhibits conversation; staff miss face-to-face contact with patients and the satisfaction it 
brings3,4. Evidence is still emerging, but it seems that the level of care has been reduced, particularly 
for the elderly and those with long term conditions37. Some of this could be due to the diminished 
efficacy of video consultations, or indeed to reluctance to use it, and this needs to be researched in 
due course.   
This brings us to the last question and the crux of this paper: how can we go from here to successful 
implementation of video consultations for the long-term? The crisis has provided a golden 
opportunity for large scale usage to be researched and for the findings of earlier research to be 
revisited. Some of the barriers may prove to be overstated. In the light of experience, professional 
users may find that the technology is more useful and easier to use than they had feared. However, 
some issues will not go away and will become glaringly obvious when studied at scale. There is no 
doubt, for instance, that working at home and sitting in front of a screen all day, alone, is more tiring 
than interacting with colleagues in a work environment. We have all experienced the eye strain, 
muscle ache, restlessness and inability to concentrate after long sessions. These concerns require 
creative approaches, as do the real concerns over job roles and ways to support digitally challenged 
users (staff and patients). However, there is an opportunity to gather the evidence now and start the 
conversation.  
Fisk et al. argue that the ‘Covid-19 outbreak was a major “jolt” to the National Health Service, that 
had been and remains, in part, reluctant to embrace telehealth’9. Innovation should not be left to 
‘champions’ who are prepared to defend and refine their ideas until they are grudgingly accepted. It 
should be the responsibility of senior management and all layers of staff, recognising that the 
process involves building an evidence base and addressing problems in an open and transparent 
way. These concerns should still apply during the current crisis and in the longer term. 
However, what has radically changed in the new world is ‘perceived usefulness’. Health 
professionals – and perhaps more particularly, senior management – recognise that the service level 
can only be maintained safely by using video. Where compromise is necessary – due to the patient’s 
circumstances or the need for physical care – it places the health professional at greater risk of 
infection. Suddenly there is a compelling reason to overcome all the issues and ‘perceived 
usefulness’ trumps ‘perceived ease of use’. 
This is laudable and necessary during the crisis, but there is a real possibility that the use of video 
will be part of the ‘new normal’. Whilst this will be welcomed by patients, there needs to be an open 
discussion with professionals. Research has shown that there has been much passive resistance to 
video consultations and technology enabled care, and that some of the objections can be mutually 
overcome if managers and staff work together. For example, the lack of confidence in using the 
technology can be overcome by a greater investment in service design, training and safe 
experimentation by staff and service users29. The issue of job loss concern and dissonance with 
professional identity are both related to service transformation, in which new roles are emerging 
and older ones being discontinued. Only by open and respectful discussion can this be done fairly: a 
process that has been almost impossible under the austerity ideology of the last ten years.  
Conclusion 
The Covid-19 pandemic crisis has meant that video consultations are being rolled out globally. In the 
UK, whilst the Scottish government accelerated its funding to support innovation, the UK 
government was slower to react on this front9. NHS England has encouraged health providers to use 
video consultation and guidelines have been rapidly written; but we do not know yet the extent of 
roll-out. Nevertheless, the efficacy and acceptability of telemedicine has been evidenced in many 
evaluations and so now is the ideal time to develop capability so that telemedicine becomes an 
integral part of health service delivery.  Whether telemedicine remains a significant part of service 
delivery in the future will depend on how useful it is perceived to be over the longer term and if 
there is a genuine benefit.  
 
 
